Verrica Pharmaceuticals/$VRCA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Ticker
$VRCA
Sector
Primary listing
Employees
71
Headquarters
Website
VRCA Metrics
BasicAdvanced
$52M
-
-$6.40
1.92
-
Price and volume
Market cap
$52M
Beta
1.92
52-week high
$7.40
52-week low
$5.29
Financial strength
Current ratio
1.259
Quick ratio
1.121
Long term debt to equity
-146.265
Total debt to equity
-222.443
Interest coverage (TTM)
-4.18%
Profitability
EBITDA (TTM)
-37.15
Gross margin (TTM)
-15.60%
Net profit margin (TTM)
-330.52%
Operating margin (TTM)
-257.42%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-51.93%
Return on equity (TTM)
315.75%
Valuation
Price to revenue (TTM)
2.824
Price to book
-2.89
Price to tangible book (TTM)
-2.89
Price to free cash flow (TTM)
-0.877
Free cash flow yield (TTM)
-114.04%
Free cash flow per share (TTM)
-6.232
Growth
Revenue change (TTM)
5.72%
Earnings per share change (TTM)
-65.87%
3-year revenue growth (CAGR)
183.55%
3-year earnings per share growth (CAGR)
-25.10%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Verrica Pharmaceuticals stock?
Verrica Pharmaceuticals (VRCA) has a market cap of $52M as of August 26, 2025.
What is the P/E ratio for Verrica Pharmaceuticals stock?
The price to earnings (P/E) ratio for Verrica Pharmaceuticals (VRCA) stock is 0 as of August 26, 2025.
Does Verrica Pharmaceuticals stock pay dividends?
No, Verrica Pharmaceuticals (VRCA) stock does not pay dividends to its shareholders as of August 26, 2025.
When is the next Verrica Pharmaceuticals dividend payment date?
Verrica Pharmaceuticals (VRCA) stock does not pay dividends to its shareholders.
What is the beta indicator for Verrica Pharmaceuticals?
Verrica Pharmaceuticals (VRCA) has a beta rating of 1.92. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.